TYPHIM-Vi

Description

The active substance is Polysaccharides of bacteria Salmonella typhi. This medicinal product is a vaccine indicated in the prevention of typhoid fever in adults and in children over 2 years of age.

IMMUNIZATION GUIDELINE

A single injection ensures protection. Immunity appears within 2 to 3 weeks after injection. Revaccination should be performed every 3 years if the risk of exposure continues.

The vaccination schedule is the same for children and for adults. TYPHIM Vi is especially indicated for people living in or travelling to endemic areas, migrants, health care professionals and military personnel.

For latest IAP updates see revised immunization schedule.

Additional information

vaccine-type

Polysacharide typhoid vaccine

manufacturer

Sanofi Pasteur

country-of-manufacture

France

pharmaceutical-form

Liquid

package-size

20 Dose

route-of-administration

Intramuscular

preservative

Phenol

Contraindications

Do not use TYPHIM Vi if you or your child are/is allergic to any ingredient of the vaccine, suffer/suffers from fever, an acute disease, a progressive chronic disease (in which case vaccination should be postponed)